Commonwealth Equity Services’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$444K Sell
32,017
-7,437
-19% -$118K ﹤0.01% 3314
2025
Q4
$641K Sell
39,454
-2,097
-5% -$34.2K ﹤0.01% 2963
2025
Q3
$622K Buy
41,551
+5,008
+14% +$61K ﹤0.01% 2996
2025
Q2
$426K Sell
36,543
-9,500
-21% -$86.3K ﹤0.01% 3288
2025
Q1
$342K Buy
46,043
+415
+0.9% +$3.19K ﹤0.01% 3379
2024
Q4
$274K Buy
45,628
+50
+0.1% +$276 ﹤0.01% 3498
2024
Q3
$233K Sell
45,578
-50
-0.1% -$218 ﹤0.01% 3565
2024
Q2
$165K Sell
45,628
-333
-0.7% -$1.06K ﹤0.01% 3695
2024
Q1
$148K Sell
45,961
-327
-0.7% -$1.26K ﹤0.01% 3715
2023
Q4
$227K Sell
46,288
-8,976
-16% -$41K ﹤0.01% 3405
2023
Q3
$301K Buy
55,264
+3,498
+7% +$23.1K ﹤0.01% 3033
2023
Q2
$347K Buy
51,766
+1,800
+4% +$13.4K ﹤0.01% 2922
2023
Q1
$441 Sell
49,966
-5,035
-9% -$44.4K ﹤0.01% 2663
2022
Q4
$420K Buy
55,001
+1,300
+2% +$10.1K ﹤0.01% 2608
2022
Q3
$382K Buy
53,701
+1,225
+2% +$11.5K ﹤0.01% 2626
2022
Q2
$424K Sell
52,476
-1,390
-3% -$12.2K ﹤0.01% 2537
2022
Q1
$747K Buy
53,866
+6,701
+14% +$105K ﹤0.01% 2215
2021
Q4
$1.32M Sell
47,165
-14,901
-24% -$457K ﹤0.01% 1792
2021
Q3
$2.11M Sell
62,066
-2,743
-4% -$99.2K 0.01% 1397
2021
Q2
$2.65M Buy
64,809
+22,653
+54% +$881K 0.01% 1244
2021
Q1
$1.7M Sell
42,156
-225
-0.5% -$12.2K ﹤0.01% 1442
2020
Q4
$2.5M Sell
42,381
-894
-2% -$46.1K 0.01% 1099
2020
Q3
$2.1M Buy
43,275
+1,116
+3% +$46.9K 0.01% 1067
2020
Q2
$2.04M Buy
42,159
+36
+0.1% +$1.31K 0.01% 1020
2020
Q1
$1.17M Buy
+42,123
New +$1.17M 0.01% 1178

Other funds holding ADPT